CM-P lowered blood glucose and INS levels, enhanced insulin sensitivity, improved disorders of glucose–lipid metabolism, alleviated oxidative stress and inflammatory responses, and repaired diabetes-related organ damage. The gene discussed is INS; the disease is diabetes mellitus.